LMC INTERNATIONAL LIMITED

Financial Health Assessment: LMC INTERNATIONAL LIMITED

1. Financial Health Score: B+

Explanation: The company exhibits exceptionally strong financial vitals for the year ending April 2022, with a robust cash position, eliminated long-term liabilities, and strong profitability. However, the "patient" has undergone a major surgical procedure: the core trade, assets, and operational liabilities were transferred to its parent company on the exact date of the financial year-end. Consequently, while the remaining corporate shell is financially liquid and healthy, it has ceased trading. The high score reflects the pristine condition of the remaining assets and the successful, low-risk nature of the corporate restructuring, rather than an ongoing trading enterprise.

2. Key Vital Signs (As of 30 April 2022)

• Net Assets (Total Body Mass): £1,646,811 (Up 94% from £847,342 in 2021). The company’s net worth has nearly doubled, indicating a massive accumulation of retained wealth.
• Cash Position (Blood Flow): £966,152. Although slightly down from the prior year (£1,287,205), the company still holds a substantial amount of cash, ensuring excellent short-term liquidity and no risk of a cash flow heart attack.
• Current Liabilities (Cholesterol/Toxins): £333,072 (Down 78% from £1,492,850 in 2021). The dramatic reduction in short-term debts indicates that a significant amount of "bad cholesterol" has been cleared from the system, likely tied to the intercompany restructuring.
• Profitability (Metabolic Rate): £748,471 profit for the year. The business generated strong profits in its final year of trading, showing a highly efficient metabolism before operations were transferred.

3. Diagnosis: Successful Corporate Transplant

The financial data reveals a fascinating clinical picture. On the surface, the patient looks incredibly healthy—liabilities have plummeted, net assets have surged, and profitability is strong. However, the notes to the financial statements provide the crucial medical history: As at 30 April 2022, the company ceased trading.

The trade, assets, and liabilities (excluding cash, intercompany balances, and tax) were surgically transferred to the parent company, GlobalData UK Limited. This is not a symptom of distress or an emergency amputation; rather, it is a planned "corporate transplant." The healthy, functioning parts of LMC International Limited have been successfully integrated into the wider GlobalData Plc group anatomy to simplify the group structure.

What remains of LMC International Limited is a healthy but dormant shell. It holds substantial cash, retains some debtor balances (£1,013,731), and owes a relatively small amount to creditors, but it no longer has a pulse as a trading entity. The previous year's high liabilities were largely intercompany debts that were settled or restructured as part of this transfer, explaining the dramatic drop in the liabilities figure.

4. Recommendations: Post-Operative Care

While the financial vitals of the remaining shell are strong, the company's operational heart has been transplanted. To ensure ongoing financial wellness and compliance:

• Manage the Dormant Shell: With trading ceased, the directors should ensure that the remaining cash and debtors are efficiently managed. The cash reserves of nearly £1m should be appropriately managed, potentially via group repayment or investment, in accordance with the parent company's treasury policies.
• Prepare for Hibernation or Dissolution: Since the company has ceased trading and exists solely to hold residual balances, steps should be taken to either formally declare it dormant (if it will hold assets long-term) or strike it off the register (if the remaining cash and debtors are fully cleared/transfered). Maintating an active company with multiple directors and secretaries incurs unnecessary administrative overhead.
• Ongoing Compliance: The company must continue to file Confirmation Statements and dormant accounts (if applicable) on time. The next accounts are due by 30 September 2026, and it is vital that these clearly reflect the non-trading status to avoid regulatory penalties.
• Clear Remaining Debtors: The £1m debtor balance should be reviewed. If these are intercompany balances, they should be settled systematically. If they are external, they need active collection before the company is eventually wound down.